Early (&lt; 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Q24194710)

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Feasibility study of early blood pressure management in extremely preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Maternal nutrition and birth weight. These factors are related

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

The effects of early postnatal dexamethasone therapy on pulmonary outcome in premature infants with respiratory distress syndrome: a two-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Pulse dexamethasone does not impair growth and body composition of very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: II. Respiratory status, growth, and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Dexamethasone therapy increases infection in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on regional brain volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

A three year follow up of preterm infants after moderately early treatment with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Early (4-7 days of age) dexamethasone therapy for prevention of chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Early dexamethasone treatment in preterm infants treated with surfactant: a double blind controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Growth retardation after dexamethasone administration: assessment by knemometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

The influence of betamethasone and dexamethasone on motor development in young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Inflammatory mediators and bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Clinical trials of postnatal corticosteroids: inhaled and systemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Randomized placebo-controlled trial of a 42-Day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Trial of early neonatal hydrocortisone: two-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Caffeine Therapy for Apnea of Prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Early postnatal dexamethasone treatment and increased incidence of cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

The therapeutic use of glucocorticoid hormones in the perinatal period: Potential neurological hazards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Early dexamethasone therapy in preterm infants: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Effect of dexamethasone therapy on the neonatal ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Single-dose dexamethasone treatment of hypotension in preterm infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Using cerebral palsy data in the evaluation of neonatal intensive care: a warning

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Influence of early postnatal dexamethasone therapy on ventilator dependency in surfactant-substituted preterm infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

More trials on early treatment with corticosteroids are needed

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Vascular endothelial growth factor in pulmonary lavage fluid from premature infants: effects of age and postnatal dexamethasone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Early low-dose hydrocortisone in very preterm infants: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Influence of postnatally administered glucocorticoids on rat lung growth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Dexamethasone treatment of infants at risk for chronic lung disease: surfactant components and inflammatory parameters in airway specimens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease in Preterm Infants With Respiratory Distress Syndrome: A Multicenter Clinical Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Early dexamethasone therapy and blood cell count in preterm infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Early dexamethasone-attempting to prevent chronic lung disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021

Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001146.PUB4

7 January 2021